Published in Proc Natl Acad Sci U S A on February 01, 1970
Isolation and characterization of adenovirus messenger ribonucleic acid in productive infection. J Virol (1972) 3.83
Role of DNA-dependent RNA polymerases II and III in transcription of the adenovirus genome late in productive infection. Proc Natl Acad Sci U S A (1974) 2.95
Effect of cycloheximide on RNA metabolism early in productive infection with adenovirus 2. J Virol (1974) 2.56
Relationship of mRNA from productively infected cells to the complementary strands of adenovirus type 2 DNA. J Virol (1974) 2.52
Transcription of the adenovirus genome by an -amanitine-sensitive ribonucleic acid polymerase in HeLa cells. J Virol (1972) 2.29
Possible role of the 72,000 dalton DNA-binding protein in regulation of adenovirus type 5 early gene expression. J Virol (1978) 2.01
Effect of protein synthesis inhibitors on viral mRNA's synthesized early in adenovirus type 2 infection. J Virol (1978) 1.89
Analysis of early adenovirus 2 RNA using Eco R-R1 viral DNA fragments. J Virol (1975) 1.80
Isolation of DNA Strand-specific early messenger RNA species in cells infected by human adenovirus 2. Proc Natl Acad Sci U S A (1974) 1.71
Localization of adenovirus 2 messenger RNA's to segments of the viral genome defined by endonuclease R-R1. Proc Natl Acad Sci U S A (1974) 1.47
Viral transcription in KB cells infected by temperature-sensitive "early" mutants of adenovirus type 5. J Virol (1976) 1.45
Two classes of cytoplasmic viral RNA synthesized early in productive infection with adenovirus 2. J Virol (1974) 1.37
Virus-specific messenger RNA and nascent polypeptides in polyribosomes of cells replicating murine sarcoma-leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.30
Transcription of the genome of adenovirus type 12. I. Viral mRNA in abortively infected and transformed cells. J Virol (1975) 1.26
Synthesis of viral ribonucleic acid during restricted adenovirus infection. J Virol (1972) 1.19
Identification of early adenovirus type 2 RNA species transcribed from the left-hand end of the genome. J Virol (1975) 1.11
mRNA from the transforming segment of the adenovirus 2 genome in productively infected and transformed cells. J Virol (1976) 1.11
Genome expression and mRNA maturation at late stages of productive adenovirus type 2 infection. J Virol (1976) 1.03
The mechanism of viral carcinogenesis by DNA mammalian viruses: RNA transcripts containing viral and highly reiterated cellular base sequences in adenovirus-transformed cells (DNA-RNA hybridization-viral-cell mRNA). Proc Natl Acad Sci U S A (1972) 0.93
Inactivation of T antigen-forming capacites of simian virus 40 and adenovirus 12 by ultraviolet irradiation. J Virol (1971) 0.92
Sequence relationships between adenovirus 2 early RNA and viral RNA size classes synthesized at 18 hours after infection. J Virol (1975) 0.92
Adenovirus type 2 nuclear RNA accumulating during productive infection. J Virol (1977) 0.81
Virus-specific ribonucleic acid in the nucleus and cytoplasm of rat embryo cells transformed by adenovirus type 2. J Virol (1972) 0.78
Formation of cellular deoxyribonucleic acid during productive polyoma virus infection. J Virol (1970) 0.77
Transport of viral RNA in kb cells infected with adenovirus type 2. J Cell Biol (1971) 0.75
Contributory role of viral infection in congenital tumour development. Ecancermedicalscience (2013) 0.75
Amino acid metabolism in mammalian cell cultures. Science (1959) 55.21
A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane. J Mol Biol (1965) 32.99
SPECIFIC ADENOVIRUS COMPLEMENT-FIXING ANTIGENS IN VIRUS-FREE HAMSTER AND RAT TUMORS. Proc Natl Acad Sci U S A (1963) 10.02
Activation of production of infectious tumor virus SV40 in heterokaryon cultures. Proc Natl Acad Sci U S A (1967) 6.05
Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55
Regulation of transcription of the SV40 DNA in productively infected and in transformed cells. Proc Natl Acad Sci U S A (1968) 4.80
Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65
BIOCHEMICAL STUDIES ON ADENOVIRUS MULTIPLICATION, VI. PROPERTIES OF HIGHLY PURIFIED TUMORIGENIC HUMAN ADENOVIRUSES AND THEIR DNA. Proc Natl Acad Sci U S A (1964) 4.54
Production of SV40 virus in heterokaryons of transformed and susceptible cells. Proc Natl Acad Sci U S A (1967) 4.14
Transformation of primary rat embryo cells by adenovirus type 2. Proc Natl Acad Sci U S A (1967) 2.53
Biochemical studies on adenovirus multiplication. III. Requirement for DNA synthesis. Virology (1962) 2.04
Biochemical studies on adenovirus multiplication. XV. Transcription of the adenovirus type II genome during productive infection. Virology (1969) 1.94
A method for determining the fraction of the viral genome transcribed during infection and its application to adenovirus-infected cells. Proc Natl Acad Sci U S A (1968) 1.60
Mechanism of viral carcinogenesis by DNA mammalian viruses. V. Properties of purified viral-specific RNA from human adenovirus-induced tumor cells. J Mol Biol (1968) 1.46
BIOCHEMICAL STUDIES ON ADENOVIRUS MULTIPLICATION. 8. ANALYSIS OF PROTEIN SYNTHESIS. Virology (1965) 1.18
The mechanism of viral carcinogenesis by DNA mammalian viruses. VI. A new class of virus-specific RNA molecules in cells transformed by group C human adenoviruses. Proc Natl Acad Sci U S A (1969) 1.13
A simple purification procedure for adenovirus type 12T and tumor antigens and some of their properties. Virology (1968) 0.98
Adenovirus DNA. I. Molecular weight and conformation. Proc Natl Acad Sci U S A (1967) 5.55
An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
Fake artesunate in southeast Asia. Lancet (2001) 3.84
Functional domains of adenovirus type 5 E1a proteins. Cell (1987) 3.79
A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity. Proc Natl Acad Sci U S A (1973) 3.71
Oncogenic viruses. Annu Rev Biochem (1970) 3.65
Vancomycin susceptibility and identification of motile enterococci. J Clin Microbiol (1991) 3.61
Biochemical studies on adenovirus multiplication. 18. Resolution of early virus-specific RNA species in Ad 2 infected and transformed cells. Virology (1971) 3.54
Mechanism of carcinogenesis by RNA tumor viruses. I. An RNA-dependent DNA polymerase in murine sarcoma viruses. Proc Natl Acad Sci U S A (1970) 3.47
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication. J Biol Chem (2000) 3.13
Occupational asthma in an electronics factory. Thorax (1979) 3.03
Biochemical studies on adenovirus multiplication, XIX. Resolution of late viral RNA species in the nucleus and cytoplasm. Proc Natl Acad Sci U S A (1971) 3.02
Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation. Nature (1976) 3.01
Isolation of a human papillomavirus from a patient with epidermodysplasia verruciformis: presence of related viral DNA genomes in human urogenital tumors. Proc Natl Acad Sci U S A (1982) 2.90
Immunoautoradiographic detection of proteins after electrophoretic transfer from gels to diazo-paper: analysis of adenovirus encoded proteins. Proc Natl Acad Sci U S A (1981) 2.88
Multiple functional domains of human transcription factor IIB: distinct interactions with two general transcription factors and RNA polymerase II. Genes Dev (1993) 2.87
The maximal sniff in the assessment of diaphragm function in man. Clin Sci (Lond) (1985) 2.83
Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project. JAMA (1990) 2.82
Biochemical studies on adenovirus multiplication. IX. Chemical and base composition analysis of 28 human adenoviruses. Proc Natl Acad Sci U S A (1965) 2.79
DNA hybridization and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J Clin Microbiol (1995) 2.69
Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol (1993) 2.59
The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics (1997) 2.55
Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondylarthropathy. Arthritis Rheum (1998) 2.51
Measurement of twitch transdiaphragmatic, esophageal, and endotracheal tube pressure with bilateral anterolateral magnetic phrenic nerve stimulation in patients in the intensive care unit. Crit Care Med (2001) 2.47
Viral RNA subunits in cells transformed by RNA tumor viruses. Science (1972) 2.44
The effects of ventilation of dogs with different gas mixtures on airway calibre and lung mechanics. J Physiol (1966) 2.42
Carrying large fuel loads during sustained bird flight is cheaper than expected. Nature (2001) 2.41
The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev (1997) 2.38
Mechanism of carcinogenesis by RNA tumor viruses. 3. Formation of RNA, DNA complex and duplex DNA molecules by the DNA polymerase (s) of avian myeloblastosis virus. Proc Natl Acad Sci U S A (1970) 2.37
Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain. Proc Natl Acad Sci U S A (1975) 2.37
Reduction of transmission of shigellosis by control of houseflies (Musca domestica) Lancet (1991) 2.30
Work-related respiratory disease in employees leaving an electronics factory. Thorax (1979) 2.29
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Formation of viral RNA-DNA hybrid molecules by the DNA polymerase of sarcoma-leukaemia viruses. Nature (1970) 2.27
The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol (1993) 2.27
The genome of RNA tumor viruses contains polyadenylic acid sequences. Proc Natl Acad Sci U S A (1972) 2.23
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors. Ann Oncol (2005) 2.23
Structure and gene organization in the transformed Hind III-G fragment of Ad12. Cell (1980) 2.22
Virus specific RNA in cells transformed by RNA tumour viruses. Nat New Biol (1971) 2.22
Survival among women with triple receptor-negative breast cancer and brain metastases. Ann Oncol (2009) 2.21
The mechanism of viral carcinogenesis by DNA mammalian viruses: viral-specific RNA in polyribosomes of adenovirus tumor and transformed cells. Proc Natl Acad Sci U S A (1966) 2.19
A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol (1995) 2.16
Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses. Virology (1967) 2.16
Thirty-one human adenovirus serotypes (Ad1-Ad31) form five groups (A-E) based upon DNA genome homologies. Virology (1979) 2.14
Effects of temperature on Vitalograph spirometer readings. Thorax (1983) 2.13
Physicochemical characterization of adeno-associated satellite virus type 4 and its nucleic acid. J Virol (1967) 2.10
The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun (2000) 2.10
RNA-directed DNA polymerase--properties and functions in oncogenic RNA viruses and cells. Prog Nucleic Acid Res Mol Biol (1974) 2.10
Molecular interactions of ribosomal components. I. Identification of RNA binding sites for individual 30S ribosomal proteins. Mol Gen Genet (1970) 2.09
ERp99, an abundant, conserved glycoprotein of the endoplasmic reticulum, is homologous to the 90-kDa heat shock protein (hsp90) and the 94-kDa glucose regulated protein (GRP94). J Biol Chem (1987) 2.09
Human adenoviruses: growth, purification, and transfection assay. Methods Enzymol (1979) 2.06
Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol (1997) 2.05
Preparation and characterization of highly radioactive in vitro labeled adenovirus DNA and DNA restriction fragments. Biochemistry (1977) 2.04
Variability of maximum expiratory flow-volume curves. J Appl Physiol (1974) 2.03
Sequence relatedness between the subunits of avian myeloblastosis virus reverse transcriptase. J Biol Chem (1975) 2.01
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Biochemical studies on adenovirus multiplication. XV. Transcription of the adenovirus type II genome during productive infection. Virology (1969) 1.94
Migration along orthodromic sun compass routes by arctic birds. Science (2001) 1.92
Molecular interactions of ribosomal components. II. Site-specific complex formation between 30S proteins and ribosomal RNA. Mol Gen Genet (1971) 1.91
Assessment of diaphragm weakness. Am Rev Respir Dis (1988) 1.90
The stress response in Chinese hamster ovary cells. Regulation of ERp72 and protein disulfide isomerase expression and secretion. J Biol Chem (1990) 1.89
Fall in vital capacity with posture. Br J Dis Chest (1985) 1.89
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine (2001) 1.86
An anatomical explanation for good-prognosis rheumatoid arthritis. Lancet (1999) 1.84
Indole-3-Acetic Acid and Flowering. Science (1948) 1.84
Ribonuclease H: a ubiquitous activity in virions of ribonucleic acid tumor viruses. J Virol (1972) 1.84
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83
Identification of families of overlapping polypeptides coded by early "transforming" gene region 1 of human adenovirus type 2. Virology (1979) 1.83
ERp72, an abundant luminal endoplasmic reticulum protein, contains three copies of the active site sequences of protein disulfide isomerase. J Biol Chem (1990) 1.83
Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses. Nat New Biol (1971) 1.80
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood (1982) 1.79
The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer (2007) 1.79
The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum (1999) 1.78
Use of FK 506 in pediatric patients. Transplant Proc (1991) 1.77
Occupational asthma in an electronics factory: a case control study to evaluate aetiological factors. Thorax (1979) 1.77
Biochemical studies on adenovirus multiplication. XIV. Macromolecule and enzyme synthesis in cells replicating oncogenic and nononcogenic human adenovirus. Virology (1969) 1.75
Different mode of action of ribonuclease H in purified alpha and alpha beta ribonucleic acid-directed deoxyribonucleic acid polymerase from avian myeloblastosis virus. J Biol Chem (1974) 1.74
Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 1.73
Establishment and characterization of rat cell lines transformed by restriction endonuclease fragments of adenovirus 12 DNA. Virology (1977) 1.71
Isolation of DNA Strand-specific early messenger RNA species in cells infected by human adenovirus 2. Proc Natl Acad Sci U S A (1974) 1.71
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation. Virology (1999) 1.70
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation (1999) 1.70
A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague. Vaccine (1997) 1.70
Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ (1990) 1.69
Internal combustion and health. BMJ (1990) 1.67
Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol (1991) 1.66
A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 1.65
Detection of adenovirus type 2-induced early polypeptides using cycloheximide pretreatment to enhance viral protein synthesis. J Virol (1976) 1.64
Physician satisfaction with primary care office visits. Collaborative Study Group of the American Academy on Physician and Patient. Med Care (1993) 1.64
Phrenic nerve stimulation in normal subjects and in patients with diaphragmatic weakness. Thorax (1987) 1.63
Spatial variation of natural radiation and childhood leukaemia incidence in Great Britain. Stat Med (1996) 1.63
How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med (1996) 1.62
Evaluation of a portable clinical blood analyzer in the emergency department. Acad Emerg Med (1995) 1.62
Neuroleptic malignant syndrome. Review of response to therapy. Arch Intern Med (1989) 1.61